The manufacture of vaccines in Morocco is the culmination of several years of planning and studies, said Azeddine Ibrahimi, member of the Technical Scientific Committee for the management of Covid-19. Speaking at an international forum on health vigilance, organized by the Ibn Tofail University (UIT) of Kenitra from July 15 to 17, Ibrahimi stressed that studies have been carried out for several years for the production of vaccines at the national level, specifying that the Covid-19 pandemic has accelerated the process. Ibrahimi, also director of the biotechnology laboratory of the Faculty of Medicine and Pharmacy in Rabat, praised the “flexible and efficient” national approach in the management of Covid-19, recalling that Morocco has adopted a proactive policy in its fight against the spread of the pandemic. For her part, the director of the Moroccan Anti Poison and Pharmacovigilance Center (CAPM), Rachida Soulaymani Bencheikh noted that the theme of health vigilance is now essential in the debates, stressing the importance of this meeting which constitutes a plus for students and researchers in this field, with a view to facing the challenges of the future. More than 700 experts and researchers from 28 countries take part in the forum, organized in hybrid mode (in-person and via teleconference).
- Brussels: Sahrawi Female Activists Expose Separatists’ Baseless Allegations
- President of Uruguay Receives Upper House Speaker in Montevideo
- Senegalese Minister of Environment Welcomes Historic Relations between Morocco and Senegal
- Gov’t Committed to Complete Important Projects Resulting from Constitutional Reform – Minister –
- Advanced Regionalization: Progress Made in Southern Provinces Highlighted